Literature DB >> 33478594

LncRNA NEAT1 promotes nucleus pulposus cell matrix degradation through regulating Nrf2/ARE axis.

Cheng Li1, Xinjian Ma2, Chenfei Ni1, Jingyan Xu3, Yinfei Xie3, Junwei Kan1, Xiaoli Wei4.   

Abstract

BACKGROUND: This study aimed to assess the role and mechanism of lncRNA NEAT1 in intervertebral disc degeneration (IVD).
METHODS: LncRNA profile (GSE56081) between IVD and healthy control was downloaded from the Gene Expression Omnibus (GEO) database and analyzes differential lncRNA expression. Expression of lncRNA NEAT1 in IVD tissue and TNF-α/IL-1β-stimulated nucleus pulposus cells were further measured by RT-PCR. The lncRNA NEAT1 overexpression plasmids (pcDNA-NEAT1) were constructed and transfected into nucleus pulposus cells. Catabolic biomarkers (MMP-3 and MMP-13), anabolic biomarkers (Col II and Aggrecan) and Nrf2 expression were further measured. To further investigate the function of Nrf2, nucleus pulposus cells were pretreated with or without 25 μM tert-Butylhydroquinone (TBHQ), a Nrf2 activator, for 18 h and subsequently cotreated with pcDNA-NEAT1.
RESULTS: A total of 1432 lncRNAs were differentially expressed in GSE56081. Bioinformatic analysis found that these lncRNAs mainly enriched in Nrf2/ARE signaling pathway. LncRNA NEAT1 was highly expressed in IVD tissues than that of healthy control. Moreover, TNF-α/IL-1β induced a time- and dose-dependent increase in the mRNA expression of lncRNA NEAT1 in the nucleus pulposus cells. Overexpression of lncRNA NEAT1 abates promotes nucleus pulposus cells proliferation but induces matrix degradation. Meanwhile, nucleus and cytoplasm Nrf2 expression was significantly down-regulated by lncRNA NEAT1 upregulation. Nrf2 activator (TBHQ) could partially reverse the inhibitory effects of overexpression of lncRNA NEAT1 on matrix degradation.
CONCLUSION: Collectively, our data unveiled the lncRNA NEAT1 promotes matrix degradation by regulating Nrf2/ARE signaling pathway, suggesting a potential therapeutic for IVD in the future.

Entities:  

Keywords:  Intervertebral disc degeneration; LncRNA NEAT1; Nrf2/ARE signaling pathway

Year:  2021        PMID: 33478594      PMCID: PMC7818737          DOI: 10.1186/s40001-021-00481-2

Source DB:  PubMed          Journal:  Eur J Med Res        ISSN: 0949-2321            Impact factor:   2.175


  30 in total

1.  Long noncoding RNA NEAT1 sponges miR-129 to modulate renal fibrosis by regulation of collagen type I.

Authors:  Chen Li; Yuan-Fei Liu; Chong Huang; Yan-Xia Chen; Cheng-Yun Xu; Yan Chen
Journal:  Am J Physiol Renal Physiol       Date:  2020-06-01

Review 2.  Sirtuins and intervertebral disc degeneration: Roles in inflammation, oxidative stress, and mitochondrial function.

Authors:  Guang-Zhi Zhang; Ya-Jun Deng; Qi-Qi Xie; En-Hui Ren; Zhan-Jun Ma; Xue-Gang He; Yi-Cheng Gao; Xue-Wen Kang
Journal:  Clin Chim Acta       Date:  2020-04-26       Impact factor: 3.786

3.  Variability of T2-Relaxation Times of Healthy Lumbar Intervertebral Discs is More Homogeneous within an Individual Than across Healthy Individuals.

Authors:  A Sharma; R E Walk; S Y Tang; R Eldaya; P J Owen; D L Belavy
Journal:  AJNR Am J Neuroradiol       Date:  2020-10-08       Impact factor: 3.825

4.  The novel peptides ICRD and LCGEC screened from tuna roe show antioxidative activity via Keap1/Nrf2-ARE pathway regulation and gut microbiota modulation.

Authors:  Jiaojiao Han; Zhongbai Huang; Shasha Tang; Chenyang Lu; Haitao Wan; Jun Zhou; Ye Li; Tinghong Ming; Zaijie Jim Wang; Xiurong Su
Journal:  Food Chem       Date:  2020-05-20       Impact factor: 7.514

5.  Role of long non-coding RNA NEAT1 in the prognosis of prostate cancer patients.

Authors:  Junchao Bai; Guangyi Huang
Journal:  Medicine (Baltimore)       Date:  2020-05-29       Impact factor: 1.889

6.  LncATLAS database for subcellular localization of long noncoding RNAs.

Authors:  David Mas-Ponte; Joana Carlevaro-Fita; Emilio Palumbo; Toni Hermoso Pulido; Roderic Guigo; Rory Johnson
Journal:  RNA       Date:  2017-04-06       Impact factor: 4.942

Review 7.  Intervertebral Disc Nucleus Repair: Hype or Hope?

Authors:  Gauri Tendulkar; Tao Chen; Sabrina Ehnert; Hans-Peter Kaps; Andreas K Nüssler
Journal:  Int J Mol Sci       Date:  2019-07-24       Impact factor: 5.923

8.  LncRNA MAGI2-AS3 inhibits bladder cancer progression by targeting the miR-31-5p/TNS1 axis.

Authors:  Congyi Tang; Yi Cai; Huichuan Jiang; Zhengtong Lv; Changzhao Yang; Haozhe Xu; Zhi Li; Yuan Li
Journal:  Aging (Albany NY)       Date:  2020-11-20       Impact factor: 5.682

9.  lncRNA NEAT1 mediates sepsis progression by regulating Irak2 via sponging miR-370-3p.

Authors:  Ting Xiao; Chuihua Sun; Ying Xiao; Yunbao Li
Journal:  Biol Open       Date:  2020-06-24       Impact factor: 2.422

Review 10.  lncRNAs: function and mechanism in cartilage development, degeneration, and regeneration.

Authors:  Jian Zhu; Wei Yu; Yitian Wang; Kaishun Xia; Yuluan Huang; Ankai Xu; Qixin Chen; Bing Liu; Huimin Tao; Fangcai Li; Chengzhen Liang
Journal:  Stem Cell Res Ther       Date:  2019-11-21       Impact factor: 6.832

View more
  4 in total

1.  Identification of Core Genes and Screening of Potential Targets in Intervertebral Disc Degeneration Using Integrated Bioinformatics Analysis.

Authors:  Jianjun Li; Cheng Yu; Songjia Ni; Yang Duan
Journal:  Front Genet       Date:  2022-05-30       Impact factor: 4.772

2.  Hsa_circ_0134111 promotes intervertebral disc degeneration via sponging miR-578.

Authors:  Peng Yan; Chong Sun; Liangrui Luan; Jialuo Han; Yang Qu; Chuanli Zhou; Derong Xu
Journal:  Cell Death Discov       Date:  2022-02-08

3.  LncRNA LNCOC1 is Upregulated in Melanoma and Serves as a Potential Regulatory Target of miR-124 to Suppress Cancer Cell Invasion and Migration.

Authors:  Changhai Liu; Xiangsheng Ding; Cuie Wei; Yongdong Pei; Fanjun Meng; Yuren Zhong; Yi Liu
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-04-26

Review 4.  The Nrf2 antioxidant defense system in intervertebral disc degeneration: Molecular insights.

Authors:  Qian Xiang; Yongzhao Zhao; Jialiang Lin; Shuai Jiang; Weishi Li
Journal:  Exp Mol Med       Date:  2022-08-17       Impact factor: 12.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.